Author: Bob Kohut

Bob Kohut
Bob Kohut

Bob Kohut has been writing about finance for more than 30 years. As an active trader he brings a unique perspective to share market trading and investing issues.

feedback or questions?

Include your name, the article headline and your message.

EMAIL THE AUTHOR

FOLLOW ELSEWHERE

Recent and archived work by Bob Kohut for The Bull:

WAAAX Stocks – Buy or Stay Away

While the COVID 19 Pandemic ravaged sectors like energy, utilities, and industrials – all down more than 10% for the year 2020 – the Information Technology sector shined. Led by two residents of the ASX WAAAX stocks – Afterpay and Xero – the sector was up a staggering 57% for the year, dwarfing the 18.2%…

Lithium Stocks in 2021

The first trading week of a new year is a time when investors of all stripes reexamine their holdings. Some look to expand their existing holdings or add to their portfolios while others choose to stand pat, convinced the “wall of worry” of the moment from a volatile year will persist. Investors in both camps…

Junior Iron Ore Miners Ramping Up

Remember the death of the mining boom? A few days ago in an interview with news.com.au, a Deloitte economist made the following observation: “Iron ore prices are close to the peak prices we saw during the mining boom, which is remarkable considering economic conditions and the fact that China’s economy is not as strong as…

ASX Uranium Stocks to Watch

On 11 March of 2011, an earthquake and subsequent tsunami struck Japan with the Fukushima nuclear power generation plant in its wake. The damage caused by the event led to the worst global nuclear accident since the disaster at Chernobyl in 1986. The incident also dashed the hopes for expanded use of nuclear power in…

Environmental Intelligence Tailwinds for the Cleantech Sector

It is official. Australia’s first recession in more than three decades ended with the welcome announcement our economy grew at a 3.3% rate for the September Quarter. The outlook for the remainder of 2020 is positive as well, with good news on the exports front, home lending, and construction. The situation in the US appears…

Healthcare Stocks on the Top 30 Short List

Vaccine euphoria propelled the US DJIA (Dow Jones Industrial Average) to an all-time high, exceeding 30,000 points before the cold reality of the breath and depth of the spread of COVID 19 in that country doused the rally with icy water. Added to the mix leading to the pause was the second straight week of…

Major ASX Oil Stocks Outperforming the Juniors

The promise of effective vaccines to ward off the threat of COVID 19 rolls on. US based biotechnology company Moderna thrilled the world with the news the preliminary results of its COVID vaccine trials were 94.5% effective. Within days, Pfizer updated its earlier findings with new data, now boasting a 95% effective rate. Johnson &…

Winners and Losers in the Wake of Positive COVID 19 Vaccine Results

Australian investors already enthused over the continuing evidence of economic recovery here got an added boost of investing adrenaline upon the news of progress on a vaccine for COVID 19 from global pharmaceutical powerhouse Pfizer Inc. (NYSE: PFE.) In a classic example of shooting first and asking questions later global market participants en masse focused…

Time for Lower Risk Dividend Payers

The Australian economy continues to show flickers of light, strengthening the case our recession is over. On 4 November, investors learned retail trade rose by 6.5% in the September quarter, adjusted for inflation, surpassing the forecast of +6.0%. The positive news further sweetened the prior announcement on 3 November that the Australian Industry Group/Housing Industry…

ASX COVID-19 Stocks Still Rising

After months of waffling over the longer term impact of the COVID 19 Pandemic on global economies, market action beginning with the trading week of 25 October appears to indicate an acceptance of the pandemic as the preeminent issue troubling investors. In the US, the twin factors of rising coronavirus cases and disappearing stimulus relief…